Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NQO2 | P16083 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA6 | P23280 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | ACP1 | P24666 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4819798 | 0.82 | ALDH1A1 (0.44) | TSHRCA2ALDH1A1CA1 | |
| SCHEMBL19995979 | 0.82 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL21218754 | 0.81 | GAA (0.40) | TSHRNQO2CA2CA4ALDH1A1 | |
| SCHEMBL549024 | 0.80 | CA1 (0.46) | TSHRNQO2CA2CA4ALDH1A1 | |
| SCHEMBL548051 | 0.76 | CA2 (0.54) | TSHRNQO2CA2CA4ALDH1A1 | |
| SCHEMBL24129828 | 0.73 | MAPT (0.50) | TSHRCA2ALDH1A1CA1GAA | |
| SCHEMBL8374077 | 0.73 | CA1 (0.46) | TSHRNQO2CA2CA4ALDH1A1 | |
| SCHEMBL31026375 | 0.73 | TSHR (0.31) | TSHRNQO2CA2CA1 | |
| SCHEMBL2266180 | 0.73 | CA2 (0.40) | TSHRNQO2CA2CA4CA1 | |
| SCHEMBL12535917 | 0.73 | TSHR (0.41) | TSHRALDH1A1ACP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240174790-A1 | CAPPED BISPHENOL POLYINDANE OLIGOMER AND COMPOSITION, METHOD OF MANUFACTURE, AND ARTICLES MADE THEREFROM | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2024-05-30 | — | — | US | disclosed |
| EP-4334376-A1 | CAPPED BISPHENOL POLYETHER OLIGOMER AND COMPOSITION, METHOD OF MANUFACTURE, AND ARTICLES MADE THEREFROM | SHPP Global Technologies B.V. (NL) | 2024-03-13 | — | — | EP | disclosed |
| WO-2023166424-A1 | COPOLYMERS DERIVED FROM DICYCLOPENTADIENE | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023135460-A1 | CAPPED POLY(PHENYLENE ETHER) AND CURABLE THERMOSETTING COMPOSITION COMPRISING THE SAME | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2023-07-20 | — | — | WO | disclosed |
| WO-2023073614-A1 | COPOLYMERS DERIVED FROM DICYCLOPENTADIENE | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2023-05-04 | — | — | WO | disclosed |
| WO-2023073558-A1 | COPOLYMER FOR CROSS-LINKABLE NETWORKS | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2023-05-04 | — | — | WO | disclosed |
| WO-2023067443-A1 | GRAFT COPOLYMER AND CURABLE THERMOSETTING COMPOSITION COMPRISING THE SAME | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2023-04-27 | — | — | WO | disclosed |
| WO-2023067442-A1 | LINEAR BLOCK COPOLYMER AND CURABLE THERMOSETTING COMPOSITION COMPRISING THE LINEAR BLOCK COPOLYMER | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2023-04-27 | — | — | WO | disclosed |
| US-8263798-B2 | Optically active quaternary ammonium salt having axial asymmetry, and method for producing alpha-amino acid and derivative thereof by using the same | NAGASE & CO., LTD. (JP) | 2012-09-11 | — | — | US | disclosed |
| US-8252952-B2 | Optically active quaternary ammonium salt having axial asymmetry, and method for producing alpha-amino acid and derivative thereof by using the same | NAGASE & CO., LTD. (JP) | 2012-08-28 | — | — | US | disclosed |
| US-20120108846-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | NAGASE & CO., LTD. (JP) | 2012-05-03 | — | — | US | disclosed |
| US-20120101310-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | NAGASE & CO., LTD. (JP) | 2012-04-26 | — | — | US | disclosed |
| US-20120101309-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | NAGASE & CO., LTD. (JP) | 2012-04-26 | — | — | US | disclosed |
| US-20120095252-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | NAGASE & CO., LTD. (JP) | 2012-04-19 | — | — | US | disclosed |
| US-20120095218-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | NAGASE & CO., LTD. (JP) | 2012-04-19 | — | — | US | disclosed |
| EP-1661129-A1 | LIMITED-PLAY RECORDABLE DATA STORAGE MEDIA AND ASSOCIATED METHODS OF MANUFACTURE | GENERAL ELECTRIC COMPANY (US) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005024811-A1 | LIMITED-PLAY RECORDABLE DATA STORAGE MEDIA AND ASSOCIATED METHODS OF MANUFACTURE | GENERAL ELECTRIC COMPANY (US) | 2005-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108846-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | AADAT, BCAT1, BCAT2 | TSHR 4039/4885NQO2 1712/4885CA2 274/4885 |
| US-20120101309-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | AADAT, BCAT1, BCAT2 | TSHR 3994/4885NQO2 393/4885CA2 392/4885 |
| US-20120095252-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | AADAT, BCAT1, BCAT2 | TSHR 4039/4885NQO2 1712/4885CA2 274/4885 |
| US-20120095218-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | AADAT, BCAT1, BCAT2 | TSHR 4039/4885NQO2 1712/4885CA2 274/4885 |
| US-20120101310-A1 | OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY, AND METHOD FOR PRODUCING ALPHA-AMINO ACID AND DERIVATIVE THEREOF BY USING THE SAME | AADAT, BCAT1, BCAT2 | TSHR 4039/4885NQO2 1712/4885CA2 274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.